Skip to main content
. Author manuscript; available in PMC: 2023 Mar 25.
Published in final edited form as: Gynecol Oncol. 2020 Dec 13;160(2):568–578. doi: 10.1016/j.ygyno.2020.12.004

Figure 1.

Figure 1.

Expression of SMARCA4 and SMARCA2 in COV434 and TOV-112D cell lines. A. Western blot analysis showing loss of SMARCA4 and SMARCA2 in COV434 and TOV-112D. B. Western blot analysis showing lentiviral-mediated re-expression of SMARCA4 in COV434 and TOV-112D. C. Growth curves demonstrate SMARCA4 re-expression dramatically inhibits the growth of COV434 and TOV-112D.